19-11466796-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001420.4(ELAVL3):āc.41G>Cā(p.Gly14Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000863 in 1,611,586 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: š 0.000053 ( 0 hom., cov: 31)
Exomes š: 0.000090 ( 0 hom. )
Consequence
ELAVL3
NM_001420.4 missense
NM_001420.4 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 5.22
Genes affected
ELAVL3 (HGNC:3314): (ELAV like RNA binding protein 3) A member of the ELAVL protein family, ELAV-like 3 is a neural-specific RNA-binding protein which contains three RNP-type RNA recognition motifs. The observation that ELAVL3 is one of several Hu antigens (neuronal-specific RNA-binding proteins) recognized by the anti-Hu serum antibody present in sera from patients with paraneoplastic encephalomyelitis and sensory neuronopathy (PEM/PSN) suggests it has a role in neurogenesis. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.06547719).
BS2
High AC in GnomAd4 at 8 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ELAVL3 | NM_001420.4 | c.41G>C | p.Gly14Ala | missense_variant | 2/7 | ENST00000359227.8 | NP_001411.2 | |
ELAVL3 | NM_032281.3 | c.41G>C | p.Gly14Ala | missense_variant | 2/7 | NP_115657.2 | ||
ELAVL3 | XM_011527778.3 | c.38G>C | p.Gly13Ala | missense_variant | 2/7 | XP_011526080.1 | ||
ELAVL3 | XM_024451413.1 | c.38G>C | p.Gly13Ala | missense_variant | 2/7 | XP_024307181.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ELAVL3 | ENST00000359227.8 | c.41G>C | p.Gly14Ala | missense_variant | 2/7 | 3 | NM_001420.4 | ENSP00000352162.1 | ||
ENSG00000267477 | ENST00000585656.1 | n.501G>C | non_coding_transcript_exon_variant | 4/5 | 5 | ENSP00000466387.1 | ||||
ELAVL3 | ENST00000438662.6 | c.41G>C | p.Gly14Ala | missense_variant | 2/7 | 5 | ENSP00000390878.1 | |||
ELAVL3 | ENST00000588853.1 | c.41G>C | p.Gly14Ala | missense_variant | 2/3 | 3 | ENSP00000467314.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152196Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
8
AN:
152196
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000578 AC: 14AN: 242364Hom.: 0 AF XY: 0.0000532 AC XY: 7AN XY: 131570
GnomAD3 exomes
AF:
AC:
14
AN:
242364
Hom.:
AF XY:
AC XY:
7
AN XY:
131570
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000898 AC: 131AN: 1459390Hom.: 0 Cov.: 33 AF XY: 0.0000937 AC XY: 68AN XY: 725904
GnomAD4 exome
AF:
AC:
131
AN:
1459390
Hom.:
Cov.:
33
AF XY:
AC XY:
68
AN XY:
725904
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152196Hom.: 0 Cov.: 31 AF XY: 0.0000538 AC XY: 4AN XY: 74348
GnomAD4 genome
AF:
AC:
8
AN:
152196
Hom.:
Cov.:
31
AF XY:
AC XY:
4
AN XY:
74348
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
5
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;.
REVEL
Benign
Sift
Benign
T;T;.
Sift4G
Benign
T;T;.
Polyphen
B;B;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at